Bioequivalence of Amphotericin B Liposome for Injection

NCT05913921 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Bioequivalence

Interventions

DRUG: Amphotericin B liposome for injection
DRUG: AmBisome

Sponsor

CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.